JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 5, 2005; DOI: 10.1124/jpet.104.079343


0022-3565/05/3131-127-133$20.00
JPET 313:127-133, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.079343v1
313/1/127    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ethier, M. F.
Right arrow Articles by Madison, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ethier, M. F.
Right arrow Articles by Madison, J. M.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Mechanisms of Interleukin-4 Effects on Calcium Signaling in Airway Smooth Muscle Cells

Michael F. Ethier, Erika Cappelluti, and J. Mark Madison

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts

In airway smooth muscle cells, interleukin (IL)-4 inhibited both carbachol- and caffeine-induced calcium mobilization from the sarcoplasmic reticulum (SR). Because of the known signaling pathways for IL-4 and importance of calcium uptake in maintaining SR calcium stores shared by agonists and caffeine, it was hypothesized that this rapid inhibitory effect might depend on phosphatidylinositol 3-kinase (PI3K) and on inhibition of calcium uptake by the SR. Enzyme-dispersed bovine trachealis cells were loaded with Fura-2/acetoxymethyl ester, and changes in cytosolic calcium were imaged in single cells. Cells were pretreated with inhibitors of PI3K, either wortmannin (100 nM), LY294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] (50 µM), or deguelin (100 nM). Calcium transients in response to carbachol (10 µM) were significantly decreased to 0.34 ± 0.10 of control after 20-min treatment with IL-4 but were 1.10 ± 0.26 and 1.08 ± 0.23 when wortmannin or deguelin, respectively, was added along with IL-4. LY294002 alone had nonspecific effects on transients. In other experiments, cyclopiazonic acid (CPA) (5 µM), an inhibitor of SR calcium uptake, decreased carbachol-stimulated transients within 4 min to 0.83 ± 0.08 of control (n = 6). However, for cells treated with IL-4 (50 ng/ml) plus CPA, transients decreased significantly more, to only 0.51 ± 0.05 (n = 6; p < 0.05). Longer exposures to IL-4 and a higher concentration of CPA (30 µM) gave similar results. It was concluded that IL-4 did not inhibit transients in the presence of PI3K antagonists but that it did in the presence of CPA. This suggested that IL-4 inhibited calcium transients by mechanisms dependent upon a wortmannin-sensitive PI3K but not by inhibition of calcium uptake into the SR.


Received for publication November 3, 2004
Accepted January 4, 2005.

Address correspondence to: Dr. J. Mark Madison, Department of Medicine, LRB Room 319, University of Massachusetts Medical School, 364 Plantation St., Worcester, MA 01605. E-mail: mark.madison{at}umassmed.edu




This article has been cited by other articles:


Home page
Exp PhysiolHome page
G. Martin, R. J. O'Connell, A. Z. Pietrzykowski, S. N. Treistman, M. F. Ethier, and J. M. Madison
Interleukin-4 activates large-conductance, calcium-activated potassium (BKCa) channels in human airway smooth muscle cells
Exp Physiol, July 1, 2008; 93(7): 908 - 918.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. A. Panettieri Jr., M. I. Kotlikoff, W. T. Gerthoffer, M. B. Hershenson, P. G. Woodruff, I. P. Hall, and S. Banks-Schlegel
Airway Smooth Muscle in Bronchial Tone, Inflammation, and Remodeling: Basic Knowledge to Clinical Relevance
Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 248 - 252.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.